The augmentation of TSAP6, a p53-regulated gene product that governs the exosomal secretion signalling transcription by activating p53, which is frequently aberrantly driven in cancer cells, could alter the rise in exosome shedding from cancer cells. The gene discussed is STEAP3; the disease is cancer.